ShockWave’s disruptive approach within the calcified cardiovascular disease space creates a first-mover advantage offering the opportunity of robust sales growth. ShockWave Medical’s business model ...
16.3 Electro Medical Systems (Ems) S.A.
SANTA CLARA, Calif., Sept. 03, 2019 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc., a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex calcified ...
As an adjunct to bypass surgery for ischemic cardiomyopathy, a cardiac shockwave therapy aimed at regenerating ischemic myocardium boosted left ventricular ejection fraction (LVEF) and physical ...
(Reuters) -Johnson & Johnson on Friday agreed to buy Shockwave Medical in a deal valued at $13.1 billion including debt, as it builds its cardiac-health-centric medical devices business to help drive ...
DUBLIN, Dec. 18, 2020 /PRNewswire/ -- The "Extracorporeal Shockwave Device Global Market Insights 2020, Analysis and Forecast to 2025, by Manufacturers, Regions, Technology, Application" report has ...
Shockwave will purchase outstanding Neovasc shares for $27.25 each, valuing the company at around $100 million, according to a Jan. 17 news release from Shockwave. Neovasc specializes in the treatment ...
ShockWave Medical, which sells medical systems used in treating cardiovascular disease, announced terms for its IPO on Monday. The Santa Clara, CA-based company plans to raise $75 million by offering ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results